-

Cemvita and Roebling Partner to Accelerate Industrial BioSolutions From Discovery to Deployment

Collaboration pairs Cemvita’s domain expertise and proprietary biological data with Roebling’s AI-native engineering to de-risk BioSolutions earlier and prepare them for deployment

HOUSTON--(BUSINESS WIRE)--Cemvita, an emerging frontier AI lab for industrial BioSolutions, today announced a partnership with Roebling, an AI-native engineering firm, to speed the discovery, evaluation and deployment of biological solutions for the natural-resource industries.

“Industrial biotechnology has never lacked promising discoveries. The challenge has been knowing early enough which technologies can become commercially viable, financeable and deployable projects,” said Moji Karimi, CEO and Co-Founder of Cemvita.

Share

Cemvita brings more than a decade of experience developing and scaling industrial biotechnology, along with proprietary biological, fermentation, process and deployment data. Through its BioSolutions Discovery Platform, the company applies these capabilities to energy, mining, chemicals, agriculture, water, waste and other natural-resource industries.

Roebling will serve as Cemvita’s engineering partner, adding AI-native process engineering and techno-economic modeling to the platform. Together, the companies will bring engineering, economic and commercial insight into development much earlier, helping Cemvita find the most viable pathways, focus its de-risking work and prepare promising BioSolutions for deployment.

“Industrial biotechnology has never lacked promising discoveries. The challenge has been knowing early enough which technologies can become commercially viable, financeable and deployable projects,” said Moji Karimi, CEO and Co-Founder of Cemvita. “Our domain expertise and proprietary data give us the foundation for a differentiated AI platform for industrial BioSolutions. Roebling helps us turn that intelligence into process configurations, project economics and deployment pathways much faster, so we can complete early de-risking sooner and increase the rate at which BioSolutions reach industry.”

Industrial projects have traditionally moved through sequential engineering cycles: technical development, then process design, then economic evaluation, then formal front-end loading (FEL). Critical commercial constraints can take months or years to surface. By using Roebling to evaluate plant configurations, capacities, feedstocks, locations, utility needs, capital and operating costs, and commercial sensitivities from the start, Cemvita expects to shorten parts of the analysis that inform FEL decisions from months to weeks.

This earlier insight will allow Cemvita to:

  • Compare more technical and commercial pathways before committing significant capital.
  • Identify the variables that most affect project viability, and design de-risking programs around them.
  • Eliminate weak opportunities sooner.
  • Advance stronger BioSolutions into formal engineering and deployment with greater confidence.

The initial collaboration will center on a configurable model of Cemvita’s FermWorks process, built from its existing Basis of Design. Roebling will run analysis across plant sizes, feedstocks, locations, process configurations and product mixes. The companies expect to extend the work to other opportunities in Cemvita’s growing BioSolutions portfolio. As individual projects advance, Roebling may also support customer-specific technical evaluation, pre-front-end engineering design (pre-FEED), FEL and deployment.

“Cemvita brings deep industrial-biotechnology expertise, proprietary data and a portfolio of real deployment opportunities,” said Edward Shenderovich, CEO and Co-Founder of Roebling. “We want to be Cemvita’s engineering partner at every stage, turning that knowledge into faster engineering and investment decisions and a more efficient path from biological possibility to industrial project.”

About Cemvita

Cemvita is building a frontier AI lab for industrial BioSolutions. Through its BioSolutions Discovery Platform, the company combines artificial intelligence, microbial intelligence, proprietary data and industrial-biotechnology expertise to discover, de-risk and deploy biological solutions for the natural-resource industries. Its work spans biological production, resource recovery, process improvement and environmental applications, backed by experience scaling biotechnology from the laboratory to industrial operations. For more information, visit www.cemvita.com.

About Roebling

Roebling is an AI-native engineering firm that partners with industrial companies to evaluate, design and advance projects, from early technical assessment through investment and deployment. Its engineers use physics-grounded AI models that connect process design, engineering assumptions and project economics, giving clients faster and more transparent answers to capital decisions. For more information, visit www.roebling.com.

Contacts

Media Contacts
Cemvita: press@cemvita.com
Roebling: Joseph Kelly, joseph@roebling.com

More News From Cemvita

Cemvita Successfully Demonstrates 75,000-Liter Industrial Scale-Up of FermOil™ Platform Using Crude Glycerin, a Byproduct of Biodiesel Production

HOUSTON--(BUSINESS WIRE)--Cemvita today announced the successful completion of a 75,000-liter industrial fermentation campaign at Bio Base Europe Pilot Plant, achieving target technical metrics for the production of FermOil™ from industrial crude glycerin. The milestone validates the scalability of Cemvita’s biomanufacturing platform. Over the past several years, Cemvita advanced the process through multiple scale-up stages, progressing from bench-scale systems through 2-liter, 30-liter, 1,500-...

Cemvita Accelerates Commercial Momentum with Complementary Technology Acquisition and Senior Hire in Brazil

HOUSTON--(BUSINESS WIRE)--Cemvita, a leader in industrial biotechnology building a scalable circular bioeconomy, today announced two practical steps that materially strengthen its ability to translate validated lab and scale up results into reliable industrial performance: a complementary technology acquisition that expands the Company’s IP and scale-up capacity, and the appointment of Dr. Luciano Zamberlan as Vice President of Operations, based in Brazil. These moves are intended to strengthen...

Cemvita Signs Agreement With Government of Rio Grande do Sul to Deploy Industrial Plant in Southern Brazil

PORTO ALEGRE, Brazil--(BUSINESS WIRE)--Cemvita, the U.S.-based industrial biotechnology company, signed today an engagement agreement with Invest RS, formalizing its plan to build a facility in Rio Grande do Sul, Brazil, for the production of FermOil™. This sustainable oil will be used as feedstock for Sustainable Aviation Fuel (SAF) production. The plant will also produce FermNPK™, an innovative biofertilizer that supports regenerative agriculture. Earlier this year, Cemvita announced a partne...
Back to Newsroom